“…Particularly, PL can be obtained from platelet concentrates by the cryogenic disruption of platelets and constitutes a protein-rich cocktail comprising several growth factors (e.g., platelet-derived growth factor (PDGF), transforming growth factor (TGF)-β, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), insulin-like growth factor (IGF), among others) and molecules A c c e p t e d M a n u s c r i p t 4 involved in cell adhesion (e.g., fibrin, fibronectin and vitronectin) [14,15]. PLderived biomaterials, including hydrogels [17][18][19][20], scaffolds [21][22][23] and patches [24,25], have been receiving great attention toward overcoming some limitations associated to bolus injections of therapeutic growth factors or platelet-derived preparations (e.g., rapid leakage, short half-life of soluble factors, denaturation, injection risks, etc. ), constituting a promising strategy for endogenous regenerative medicine.…”